Treace Medical Concepts Inc
NASDAQ:TMCI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
US |
|
A
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SSE:600063
|
CN |
|
Toyo Corp
TSE:8151
|
JP |
|
Gjensidige Forsikring ASA
OSE:GJF
|
NO |
|
Sivers Semiconductors AB
STO:SIVE
|
SE |
|
S
|
Spectral AI Inc
NASDAQ:MDAI
|
US |
|
Nippon Indosari Corpindo Tbk PT
IDX:ROTI
|
ID |
|
Live Company Group PLC
LSE:LVCG
|
UK |
|
Morito Co Ltd
TSE:9837
|
JP |
|
E
|
E-Tron Co Ltd
KOSDAQ:096040
|
KR |
|
Astral Ltd
NSE:ASTRAL
|
IN |
|
B
|
Biomimix Inc
OTC:BMMX
|
US |
|
E
|
Euroholdings Ltd
NASDAQ:EHLDV
|
GR |
Wall Street
Price Targets
TMCI Price Targets Summary
Treace Medical Concepts Inc
According to Wall Street analysts, the average 1-year price target for
TMCI
is 4.08 USD
with a low forecast of 2.02 USD and a high forecast of 7.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TMCI's stock price target?
Price Target
4.08
USD
According to Wall Street analysts, the average 1-year price target for
TMCI
is 4.08 USD
with a low forecast of 2.02 USD and a high forecast of 7.35 USD.
What is Treace Medical Concepts Inc's Revenue forecast?
Projected CAGR
3%
For the last 5 years the
compound annual growth rate for
Treace Medical Concepts Inc's revenue is
30%.
The projected
CAGR
for the next 3 years is
3%.
